Allergology International (Jan 2021)

Benralizumab as initial treatment for chronic eosinophilic pneumonia

Shusuke Yazawa,
Mikio Toyoshima,
Keigo Koda,
Takafumi Suda

Affiliations

Shusuke Yazawa: Department of Respiratory Medicine, Hamamatsu Rosai Hospital, Hamamatsu, Japan
Mikio Toyoshima: Department of Respiratory Medicine, Hamamatsu Rosai Hospital, Hamamatsu, Japan; Corresponding author. Department of Respiratory Medicine, Hamamatsu Rosai Hospital, 25 Shogencho, Hamamatsu, 430-8525, Japan.
Keigo Koda: Department of Respiratory Medicine, Hamamatsu Rosai Hospital, Hamamatsu, Japan
Takafumi Suda: Second Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan

DOI: https://doi.org/10.1016/j.alit.2020.07.005
Journal volume & issue: Vol. 70, no. 1
pp. 140 – 142

Abstract

No abstracts available.

Published in Allergology International

ISSN: 1323-8930 (Print); 1440-1592 (Online)
Publisher: Elsevier
Country of publisher: Netherlands
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
Website: https://www.journals.elsevier.com/allergology-international/

About the journal